Daxxify vs Botox: Differences
Daxxify and Botox are injectable treatments that temporarily relax selected facial muscles to reduce the appearance of expression-related wrinkles. Although both use botulinum toxin type A, they differ in formulation, approved cosmetic applications, recommended dosing and the length of time their effects may remain.

What Are Daxxify and Botox?
Daxxify and Botox are prescription neuromodulators used to reduce muscle activity and soften facial lines caused by repeated expressions. Both treatments belong to the botulinum toxin type A family, but they contain distinct formulations and are not interchangeable products.
Daxxify contains daxibotulinumtoxinA-lanm and is particularly known for its longer-lasting effect in treating moderate to severe frown lines between the eyebrows. Its cosmetic use received approval in the United States in 2022, introducing another option for adults considering injectable wrinkle treatment.
Botox Cosmetic contains onabotulinumtoxinA and has a longer history of cosmetic use. It is approved in the United States for several facial concerns, including frown lines, forehead lines, crow's feet and certain vertical neck bands.
Both products offer temporary results rather than permanent changes to facial anatomy. Their differences become more relevant when considering treatment areas, maintenance appointments and how long someone wants their wrinkle reduction to last.
How Do Daxxify and Botox Work?
Daxxify and Botox reduce facial muscle activity through the same fundamental mechanism. Both inhibit the release of acetylcholine, a chemical messenger that normally carries signals from nerve endings to muscles.
When the targeted muscle receives fewer contraction signals, it moves less forcefully. The skin above that muscle consequently experiences less folding during expressions such as frowning or squinting.
This is particularly useful for dynamic wrinkles, which develop through repeated facial movements. Frown lines between the eyebrows are a familiar example, as they become more pronounced when the muscles responsible for drawing the brows together contract.
Over time, some movement-related lines remain visible even when the face is relaxed. Reducing the underlying muscle activity may soften these established creases, although it cannot necessarily remove them completely.
Neither Daxxify nor Botox adds facial volume, stimulates substantial skin tightening or replaces lost collagen. Their primary effect comes from temporarily altering muscle activity rather than directly rebuilding the skin.
What Makes the Daxxify Formulation Different?
One of the defining differences between Daxxify and Botox lies in the ingredients used to stabilize their botulinum toxin formulations.
Daxxify contains a specially designed peptide called RTP004. This peptide helps stabilize the active ingredient and distinguishes the product from conventional formulations that use human serum albumin.
Botox Cosmetic includes human albumin as part of its formulation. Albumin helps stabilize the product during preparation and storage, but the presence of a different stabilizing ingredient does not automatically establish that one injection is safer or more effective than another.
Daxxify also contains botulinum toxin without the accessory proteins found in certain other formulations. These manufacturing and formulation characteristics help distinguish it as a separate prescription medicine.
Its extended duration in clinical studies has attracted considerable attention, although the precise biological explanation for every aspect of that longer response has not been fully established.
The formulation difference matters clinically because each product has its own testing standards, dosing instructions and safety information.
What Are the Main Differences Between Daxxify and Botox?
Daxxify and Botox share a common therapeutic mechanism, but several practical distinctions influence how the products are used for cosmetic wrinkle reduction.
-
Active formulation: Daxxify contains daxibotulinumtoxinA-lanm and uses a peptide-based stabilizing system, while Botox Cosmetic contains onabotulinumtoxinA in a formulation that includes human albumin.
-
Duration of results: Daxxify demonstrated a median response of approximately six months for frown lines in pivotal clinical studies. Botox Cosmetic commonly produces improvement lasting around three to four months in the same general treatment region.
-
Approved cosmetic areas: In the United States, Daxxify is approved for moderate to severe frown lines between the eyebrows. Botox Cosmetic has additional approvals covering forehead lines, crow's feet and certain neck bands.
-
Dosing and maintenance: Each product has its own dosing units, which cannot be directly converted. Daxxify may allow longer intervals between cosmetic appointments for some patients, while Botox offers a more familiar maintenance pattern.
Which Wrinkles Can Daxxify and Botox Treat?
Both products can improve moderate to severe glabellar lines, the vertical wrinkles that form between the eyebrows when a person frowns. These lines develop through repeated activity of the corrugator and procerus muscles.
For cosmetic use in the United States, Daxxify's approved indication focuses on this specific area. Although botulinum toxin injections are sometimes discussed for other facial regions, using Daxxify outside its approved cosmetic indication requires separate consideration of available evidence and medical risk.
Botox Cosmetic has a broader range of approved cosmetic applications. In addition to frown lines, these include horizontal forehead lines, lateral eye wrinkles and certain prominent platysma bands in the neck.
The distinction matters because results demonstrated for one facial region should not automatically be assumed to apply elsewhere.
Someone primarily concerned about forehead wrinkles, for example, may benefit from understanding how Botox works on forehead lines and why the forehead and eyebrow muscles need to be assessed together.
Does Daxxify Last Longer Than Botox?
Duration is perhaps the most frequently discussed practical difference between the two treatments.
In pivotal studies of Daxxify for frown lines, the median period during which participants maintained no more than mild wrinkle severity was approximately 24 weeks, or six months. This finding supports its reputation as a longer-lasting injectable option for the glabellar region.
Botox Cosmetic typically produces improvement for around three to four months when used for frown lines according to its prescribing guidance.
However, these estimates should be interpreted carefully. They come from separate clinical studies that did not necessarily use identical evaluation methods, so the figures do not establish that Daxxify lasts exactly twice as long as Botox for every patient.
A median also does not mean everyone receives six months of visible improvement. Some people experience a shorter response, while others maintain satisfactory results for longer.
The meaningful advantage is the possibility of extended wrinkle reduction, not a guarantee of a particular number of months.
How Quickly Do Daxxify and Botox Start Working?
Neither Daxxify nor Botox creates an immediate cosmetic change because botulinum toxin requires time to influence communication between nerves and muscles.
Clinical studies of Daxxify reported a median onset of meaningful improvement around three days. Some participants noticed changes earlier, but the complete cosmetic effect continued developing after the initial response.
Botox also begins affecting muscle activity within the first several days. Many patients notice reduced movement during the first week, with the outcome becoming easier to assess over approximately one to two weeks.
Differences in how onset is measured make it difficult to conclude that one product consistently works faster in every situation.
Someone examining their frown lines the morning after treatment may still see familiar muscle movement without that indicating treatment failure.
Both products require an appropriate observation period before deciding whether the result matches the intended degree of relaxation.
Why Are Daxxify and Botox Units Not Interchangeable?
Daxxify and Botox have product-specific potency units based on different testing and manufacturing standards. Consequently, the number printed on one product's dosing instructions cannot be directly converted into an equivalent number for the other.
For their approved treatment of glabellar lines, Daxxify has a recommended total dose of 40 units, whereas Botox Cosmetic has a recommended total dose of 20 units.
These numbers do not mean that Daxxify is simply twice as strong, twice as diluted or twice as effective. Each product's units describe potency within its own validated measurement system.
Attempting to compare treatment value solely through unit counts can therefore produce misleading conclusions.
The distinction also applies to other botulinum toxin brands. The article on differences between Botox and other neuromodulators explains why formulation and product-specific dosing standards matter when evaluating injectable treatments.
A meaningful comparison should focus on treatment indication, clinical response, duration and safety rather than numerical units alone.
Is Daxxify Stronger Than Botox?
The longer average duration observed with Daxxify does not necessarily mean that it is universally stronger than Botox.
Both medicines act on the same nerve-to-muscle communication pathway. Their clinical effects depend on the formulation, the approved dosing regimen and the characteristics of the muscles being treated.
A stronger reduction in movement is not always desirable. Excessive relaxation of facial muscles can produce an unnatural expression, affect eyebrow position or create unwanted asymmetry.
Someone seeking a subtle improvement in frown lines may prefer preserving some movement, while another person may want a more pronounced reduction in muscle contraction.
Daxxify's main distinguishing feature in cosmetic treatment is its demonstrated duration in the glabellar region. That should not be confused with greater effectiveness for every wrinkle type or every facial muscle.
The appropriate treatment achieves the intended degree of relaxation without unnecessarily affecting surrounding structures.
Can Both Treatments Produce Natural-Looking Results?
Natural-looking wrinkle reduction is possible with both Daxxify and Botox because neither product automatically requires complete elimination of facial movement.
A successful result can soften the lines between the eyebrows while preserving enough muscle activity for familiar expressions. The objective is often to make the face appear more relaxed without changing its recognizable character.
However, facial muscles work together, and reducing activity in one area can influence the balance of nearby regions.
For example, weakening muscles that pull the eyebrows downward can change how the brows move during expression. Unwanted effects become more likely when muscle relationships are not considered during injection planning.
A longer-lasting treatment deserves particular consideration when appearance is a major concern. If the result feels overly restrictive, there is no immediate method that reliably reverses the effect of either neuromodulator.
The preferred outcome should therefore reflect both the desired wrinkle improvement and comfort with the duration of the change.
Who Is a Suitable Candidate for Daxxify or Botox?
Daxxify may appeal to adults with moderate to severe frown lines who prefer the possibility of maintaining improvement for a longer period between appointments.
For someone who finds regular injectable maintenance inconvenient, a longer response could be a meaningful advantage. However, the choice should not depend on duration alone.
Botox Cosmetic may be particularly relevant when several approved cosmetic areas need treatment, such as the forehead, outer eye region and glabellar lines.
People receiving botulinum toxin for the first time may also consider whether they feel comfortable with a potentially longer-lasting change in facial movement. A shorter treatment duration can offer some flexibility if they are uncertain about their preferred appearance.
Neither product is suitable for every adult. Medical history, existing muscle weakness, previous reactions and the condition of the intended injection sites must be considered.
What Happens During a Daxxify or Botox Appointment?
A cosmetic neuromodulator appointment begins with an assessment of facial movements and the wrinkles that become visible during expression.
For glabellar treatment, the patient may be asked to frown so the muscles between the eyebrows can be identified. The assessment also considers wrinkle depth at rest, existing asymmetry and eyebrow position.
After the skin is cleaned, the product is injected into selected muscles using a fine needle. Both Daxxify and Botox are administered through intramuscular injections for their approved cosmetic indications.
The procedure generally takes only a short time and does not require surgery or general anesthesia.
Mild tenderness, redness or small bumps may appear immediately afterward, although the cosmetic result develops over the following days.
The initial appointment should also establish expectations about longevity. Daxxify's potentially extended effect may be appealing, but patients should understand that its duration cannot be predicted precisely before treatment.
What Are the Possible Side Effects of Daxxify and Botox?
Daxxify and Botox share several potential complications because both temporarily interfere with nerve signals controlling muscle activity.
-
Injection-site reactions: Temporary redness, tenderness, swelling and bruising may occur after either treatment. These reactions generally improve as the injection sites recover.
-
Headaches and facial discomfort: Some patients experience headaches or an unfamiliar sensation around the treated muscles. Such symptoms are usually temporary but should be assessed if they become severe or persistent.
-
Eyelid drooping or facial asymmetry: Unintended weakening of nearby muscles can create eyelid ptosis, changes in eyebrow position or uneven expressions. The possibility of a longer-lasting result makes careful dosing especially important with Daxxify.
-
Rare serious complications: Both products carry warnings about botulinum toxin effects spreading beyond the injection site. Generalized muscle weakness, swallowing difficulty, speech changes or breathing problems require immediate emergency medical attention.
Are There Medical Reasons to Avoid Either Treatment?
Certain medical conditions can make Daxxify or Botox unsuitable or require additional precautions.
A previous serious allergic reaction to a botulinum toxin product or one of its ingredients represents an important safety concern. Active infection at the intended injection site is also a reason not to proceed with treatment.
People with disorders affecting nerve-to-muscle communication, including myasthenia gravis or related conditions, may face a greater risk of excessive muscle weakness.
Some medications can increase the effects of botulinum toxin, particularly those that interfere with neuromuscular transmission. Recent treatment with another toxin product must also be disclosed.
Adequate safety information is limited during pregnancy and breastfeeding, so elective cosmetic injections are generally postponed during these periods.
Medical screening should consider both the intended aesthetic result and the possibility of complications, regardless of which product is chosen.
What Should You Avoid After Daxxify or Botox?
Both treatments generally allow a relatively quick return to ordinary activities, but sensible aftercare helps protect the injection sites and supports a comfortable recovery.
-
Avoid forceful rubbing or massage: Strong pressure around freshly treated areas may cause irritation. Aggressive facial massage and unnecessary manipulation should be avoided during the initial recovery period.
-
Follow activity restrictions: Intense exercise and procedures that create substantial facial pressure or inflammation may need to be postponed for a short period according to the treatment instructions.
-
Do not assess the result too early: Muscle relaxation develops gradually, so persistent movement during the first few days does not necessarily indicate an ineffective injection. Additional treatment should not be arranged before the response can be properly evaluated.
-
Watch for unusual symptoms: Mild local reactions differ from significant muscle weakness, problems swallowing or difficulty breathing. Serious symptoms require urgent medical attention rather than routine home care.
How Much Does Daxxify Cost Compared With Botox?
Daxxify may have a higher upfront treatment price than Botox, although the difference cannot be established from a universal per-unit comparison.
Pricing may reflect the selected product, the treatment area, the amount required under its own dosing standards and the overall service provided.
Because Daxxify and Botox use different potency units, comparing the price of one unit from each product is not a reliable way to calculate treatment value.
The longer potential duration of Daxxify introduces another consideration. Someone who maintains improvement for approximately six months may require fewer annual appointments than a person whose Botox results last three to four months.
However, actual savings depend on the total price of each session and the duration of the individual's response.
A higher initial price does not automatically make Daxxify more expensive over an entire year, just as a longer median effect does not guarantee lower annual spending.
The useful comparison involves the total cost of maintaining satisfactory results, not simply the advertised price of one injection appointment.
Can You Switch From Botox to Daxxify?
Adults who have previously received Botox may consider Daxxify when they want to explore a longer-lasting treatment for frown lines.
Previous use of Botox does not automatically prevent treatment with Daxxify. However, switching products requires a fresh assessment because their units cannot be converted directly and their approved dosing regimens differ.
The timing of the last botulinum toxin treatment also matters. Residual muscle relaxation from an earlier injection can complicate evaluation of the next procedure.
Daxxify should not be administered more frequently than permitted by its prescribing guidance, and repeated treatment with any toxin product requires attention to cumulative exposure and clinical response.
Patients should provide accurate information about previous products, injection dates and any unusual reactions.
Switching should be viewed as selecting a new prescription medicine rather than substituting one brand name for another while maintaining the same numerical dose.
Which Treatment Makes More Sense for Your Goals?
Choosing between Daxxify and Botox begins with identifying the treatment area, the desired reduction in facial movement and the preferred maintenance schedule.
Daxxify offers an important advantage for some adults seeking longer-lasting improvement in moderate to severe frown lines. Its pivotal clinical studies demonstrated a median duration of approximately six months, potentially reducing the need for frequent appointments.
Botox Cosmetic offers an established option with a broader range of approved facial applications, making it relevant for people seeking treatment of forehead lines, crow's feet or certain neck bands in addition to frown lines.
The decision should also account for how comfortable someone feels with a longer-lasting cosmetic effect. Both products can produce unwanted muscle weakness or asymmetry, and neither has an immediate reversal method.
Differences in formulation, unit measurements and cost are meaningful, but they should not overshadow medical suitability and realistic expectations.
Ultimately, Daxxify and Botox address the same basic cause of dynamic wrinkles through separate prescription formulations. The better choice is the treatment that matches the intended facial area, provides an acceptable balance of movement and smoothing, and offers a maintenance pattern consistent with the patient's priorities.
- Last updated
- Language
- English
How did you find this article?
Subscribe to the Medifinder newsletter and never miss our latest content.


